Conjuntivitis neonatal

1. Sanfilippo CM, Allaire CM, De Cory HH. Besifloxacin ophthalmic suspension 0.6% compared with gatifloxacin ophthalmic solution 0.3% for the treatment of bacterial conjunctivitis in neonates. Drugs R D. 2017; 17(1):167–175

2. Mishori R. Chlamydia trachomatis infections: screening, diagnosis, and management. Am Fam Physician. 2012; 86(12):1127–1132

3. Honkila M, Renko M, Ik€aheimo I, Pokka T, Uhari M, Tapiainen T. A etiology of neonatal conjunctivitis evaluated in a population-based setting. Acta Paediatr. 2018; 107(5):774–779

4. Tang S, Li M, Chen H, Ping G, Zhang C, Wang S. A chronological study of the bacterial pathogen changes in acute neonatal bacterial conjunctivitis in southern China. BMC Ophthalmol. 2017; 17(1):174

5. Suhas P, Vishnu S, Muthayya M. Pathogenic bacteria and their antibiotic sensitivity in ophthalmia neonatorum. Oman J Ophthalmol. 2021; 14(2):85–87

6. Azari AA, Arabi A. Conjunctivitis: a systematic review. J Ophthalmic Vis Res. 2020; 15(3):372–395

7. Mallika P, Asok T, Faisal H, Aziz S, Tan A, Intan G. Neonatal conjunctivitis: a review. Malays Fam Physician. 2008; 3(2):77–81

8. Soto-Nogueron A, Carnalla-Barajas MN, Solorzano-Santos F, et al. Streptococcus pneumoniae as cause of infection in infants less than 60 days of age: serotypes and antimicrobial susceptibility. Int J Infect Dis. 2016; 42:69–73

9. Mayor MT. Diagnosis and management of gonococcal infections. Am Fam Physician. 2012; 86(10):931–938

10. Dias C, Gon¸calves M, Jo~ao A. Epidemiological study of hospital acquired bacterial conjunctivitis in a level III neonatal unit. Scientific World Journal. 2013; 2013:163582

11. Montagnani C, Cocchi P, Lega L, et al. Serratia marcescens outbreak in a neonatal intensive care unit: crucial role of implementing hand hygiene among external consultants. BMC Infect Dis. 2015; 15(1):11

12. Maalouli WM, Pitt MB. The eyes have it: an unusual case of Escherichia coli ophthalmia neonatorum or a shifting landscape? SAGE Open Medical Case Reports. 2017; 5:2050313X1774590

13. Dolange V, Churchward CP, Christodoulides M, Snyder LAS. The growing threat of gonococcal blindness. Antibiotics (Basel). 2018; 7(3):E59

14. Haas J, Larson E, Ross B, See B, Saiman L. Epidemiology and diagnosis of hospital-acquired conjunctivitis among neonatal intensive care unit patients. Pediatr Infect Dis J. 2005; 24(7):586–589

15. Mechel E, Trinh M, Kodsi S, Hymowitz M, Kainth MK, Lee AM. Ophthalmia neonatorum as the presenting sign of SARS-CoV-2. J AAPOS. 2021; 25(4):230–231

16. Sun H, Temeck JW, McCune SK, Chambers WA. Using historical data to support approval of drug products for ophthalmia neonatorum: innovative approach toward evidence-based medicine. JAMA Ophthalmol. 2021; 139(2):214–217

17. Matejcek A, Goldman RD. Treatment and prevention of ophthalmia neonatorum. Can Fam Physician. 2013; 59(11):1187–1190

18. Castro Ochoa KJ, Mendez MD. Ophthalmia neonatorum. In: Stat Pearls. Treasure Island, FL: Stat Pearls Publishing; 2021. http://www.ncbi.nlm.nih.gov/books/NBK551572/Accessed June 13, 2022

19. Adachi KN, Nielsen-Saines K, Klausner JD. Chlamydia trachomatis screening and treatment in pregnancy to reduce adverse pregnancy and neonatal outcomes: a review. Front Public Health. 2021;9:53107310.3389/fpubh.2021.531073

20. Smith-Norowitz TA, Ukaegbu C, Kohlhoff S, Hammerschlag MR. Neonatal prophylaxis with antibiotic containing ointments does not reduce incidence of chlamydial conjunctivitis in newborns. BMC Infect Dis. 2021; 21(1):270

21. Makker K, Nassar GN, Kaufman EJ. Neonatal conjunctivitis. In: Stat Pearls. Treasure Island, FL: StatPearls Publishing; 2021. http://www.ncbi.nlm.nih.gov/books/NBK441840/Accessed June 13, 2022

22. Lyons CJ, Lambert SR. Taylor and Hoyt’s Pediatric Ophthalmology and Strabismus E-Book. Philadelphia, PA: Elsevier Health Sciences; 2016